BR0214199A - Composições de fenóxi amina para liberar agentes ativos, forma de unidade de dosagem e método de administração - Google Patents

Composições de fenóxi amina para liberar agentes ativos, forma de unidade de dosagem e método de administração

Info

Publication number
BR0214199A
BR0214199A BR0214199-0A BR0214199A BR0214199A BR 0214199 A BR0214199 A BR 0214199A BR 0214199 A BR0214199 A BR 0214199A BR 0214199 A BR0214199 A BR 0214199A
Authority
BR
Brazil
Prior art keywords
administration
active agents
dosage unit
unit form
release active
Prior art date
Application number
BR0214199-0A
Other languages
English (en)
Inventor
David Gschneidner
Kelly Kraft
Yi Chen
Chen Zhu
Original Assignee
Emisphere Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emisphere Tech Inc filed Critical Emisphere Tech Inc
Publication of BR0214199A publication Critical patent/BR0214199A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"COMPOSIçõES DE FENóXI AMINA PARA LIBERAR AGENTES ATIVOS, FORMA DE UNIDADE DE DOSAGEM E MéTODO DE ADMINISTRAçãO". Compostos e composições de fenóxi amina para a entrega de agentes ativos são providos. Métodos de administração e preparação também são providos.
BR0214199-0A 2001-11-13 2002-11-13 Composições de fenóxi amina para liberar agentes ativos, forma de unidade de dosagem e método de administração BR0214199A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35048801P 2001-11-13 2001-11-13
US35728802P 2002-02-15 2002-02-15
PCT/US2002/036552 WO2003045306A2 (en) 2001-11-13 2002-11-13 Phenoxy amine compounds and compositions for delivering active agents

Publications (1)

Publication Number Publication Date
BR0214199A true BR0214199A (pt) 2005-01-04

Family

ID=26996636

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0214199-0A BR0214199A (pt) 2001-11-13 2002-11-13 Composições de fenóxi amina para liberar agentes ativos, forma de unidade de dosagem e método de administração

Country Status (12)

Country Link
US (1) US7297794B2 (pt)
EP (1) EP1453816B1 (pt)
JP (1) JP4602668B2 (pt)
CN (1) CN1596248B (pt)
AU (1) AU2002360387B2 (pt)
BR (1) BR0214199A (pt)
CA (1) CA2465641C (pt)
ES (1) ES2431630T3 (pt)
MX (1) MXPA04004567A (pt)
NZ (1) NZ532597A (pt)
WO (1) WO2003045306A2 (pt)
ZA (1) ZA200403572B (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2595697A (en) 1996-03-29 1997-10-22 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6991798B1 (en) 1998-08-07 2006-01-31 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
NZ523017A (en) 2000-06-29 2004-10-29 Emisphere Tech Inc Compounds and compositions for delivering active agents and preparation method thereof
BR0214199A (pt) 2001-11-13 2005-01-04 Emisphere Tech Inc Composições de fenóxi amina para liberar agentes ativos, forma de unidade de dosagem e método de administração
AU2003208945B2 (en) 2002-02-20 2008-05-01 Emisphere Technologies, Inc Method for administering GLP-1 molecules
US20040076587A1 (en) * 2002-06-19 2004-04-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical composition for intranasal administration containing a CGRP antagonist
EP1539959A2 (en) * 2002-09-18 2005-06-15 Centre Hospitalier de l'Université de Montréal (CHUM) Ghrh analogues
CA2563335A1 (en) 2004-04-16 2005-12-08 Emisphere Technologies, Inc. 8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof for delivery of active agents
ES2393324T3 (es) 2004-05-14 2012-12-20 Emisphere Technologies, Inc. Compuestos y composiciones para administrar principios activos
AU2005249410A1 (en) 2004-05-14 2005-12-15 Emisphere Technologies, Inc. Aryl ketone compounds and compositions for delivering active agents
BRPI0510906A (pt) 2004-05-19 2007-11-06 Emisphere Tech Inc composição farmacêutica tópica, composição para administração tópica e seu uso
BRPI0510820A (pt) 2004-05-19 2007-11-27 Emisphere Tech Inc composição farmacêutica, forma unitária de dosagem e seus usos
MX2007008082A (es) 2004-12-29 2007-09-05 Emisphere Tech Inc Formulaciones farmaceuticas de sales de galio.
US8110547B2 (en) 2005-01-12 2012-02-07 Emisphere Technologies, Inc. Compositions for buccal delivery of parathyroid hormone
WO2007011958A2 (en) * 2005-07-15 2007-01-25 Emisphere Technologies, Inc. Intraoral dosage forms of glucagon
CA2626029A1 (en) * 2005-11-04 2007-05-18 Genta Incorporated Pharmaceutical gallium compositions and methods
AU2007214710A1 (en) * 2006-02-15 2007-08-23 Sanofi-Aventis Novel amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
AU2007214708A1 (en) * 2006-02-15 2007-08-23 Sanofi-Aventis Novel azacycly-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
JP4857138B2 (ja) * 2006-03-23 2012-01-18 富士フイルム株式会社 レジスト組成物及びそれを用いたパターン形成方法
WO2007121318A2 (en) 2006-04-12 2007-10-25 Emisphere Technologies, Inc. Formulations for delivering insulin
US8703821B2 (en) 2006-04-18 2014-04-22 Emisphere Technologies Inc. Dialkyl ether delivery agents
WO2008003050A2 (en) 2006-06-28 2008-01-03 Emisphere Technologies, Inc. Gallium nitrate formulations
WO2008022242A2 (en) 2006-08-18 2008-02-21 Emisphere Technologies, Inc. Synthesis of propyl phenoxy ethers and use as delivery agents
EP2057112B1 (en) 2006-08-31 2018-12-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
WO2008101240A1 (en) * 2007-02-16 2008-08-21 Emisphere Technologies, Inc. Compounds having a cyclic moiety and compositions for delivering active agents
US20110039930A1 (en) 2009-08-03 2011-02-17 Emisphere Technologies, Inc. Fast-acting naproxen composition with reduced gastrointestinal effects
WO2014031874A1 (en) 2012-08-23 2014-02-27 Emisphere Technologies, Inc. Phenoxy alkyl diethanolamine and diisopropanolamine compounds for delivering active agents
MX375442B (es) 2012-09-21 2025-03-06 Intensity Therapeutics Inc Un agente terapéutico y un agente mejorador de la permeación intracelular para usarse en el tratamiento de cáncer.
WO2016128972A1 (en) 2015-02-09 2016-08-18 Entera Bio Ltd. Formulations for oral administration of active agents with controlled absorption profile
CN104961687B (zh) * 2015-06-03 2017-07-25 苏州维泰生物技术有限公司 1,2‑二嗪衍生物及其制剂、用途
MX2019001850A (es) 2016-08-17 2019-05-15 Entera Bio Ltd Formulaciones para administracion oral de principios activos.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH297705A (de) * 1950-09-16 1954-03-31 Cilag Ag Verfahren zur Herstellung eines neuen basischen Äthers.
GB710511A (en) * 1950-09-29 1954-06-16 Abbott Lab Improvements in or relating to aryl ethers of morpholino-alkanols and methods for the production thereof
GB1524260A (en) * 1976-11-23 1978-09-06 Beecham Group Ltd Aminoalkyloneoxyd substituted 4-hydroxy-3 nitrocoumarins
JPS58113178A (ja) * 1981-12-28 1983-07-05 Yamanouchi Pharmaceut Co Ltd 「お」−（１−イミダゾリル）アルキルオキシ（またはチオ）ベンゼン誘導体
US4851423A (en) * 1986-12-10 1989-07-25 Schering Corporation Pharmaceutically active compounds
CA1315279C (en) * 1987-01-12 1993-03-30 Nancy Grace Bollinger Anti-inflammatory agents
US5023253A (en) * 1987-12-21 1991-06-11 University Patents, Inc. 6-substituted mitomycin analogs
AU6062590A (en) * 1989-07-07 1991-02-06 Schering Corporation Pharmaceutically active compounds
JPH0441472A (ja) * 1990-06-05 1992-02-12 Sankyo Co Ltd グアニジノ安息香酸エステル誘導体
JPH04117461A (ja) 1990-09-07 1992-04-17 Asahi Denka Kogyo Kk 耐光性の改善された高分子材料組成物
JP2000256286A (ja) * 1999-03-11 2000-09-19 Kaken Pharmaceut Co Ltd アルキルアミン誘導体
MXPA02004092A (es) 1999-11-05 2003-02-12 Emisphere Tech Inc Compuestos y composiciones de acido fenilaminocarboxilico para administrar agentes activos.
BR0214199A (pt) 2001-11-13 2005-01-04 Emisphere Tech Inc Composições de fenóxi amina para liberar agentes ativos, forma de unidade de dosagem e método de administração
CA2563335A1 (en) * 2004-04-16 2005-12-08 Emisphere Technologies, Inc. 8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof for delivery of active agents
MX2007008082A (es) 2004-12-29 2007-09-05 Emisphere Tech Inc Formulaciones farmaceuticas de sales de galio.

Also Published As

Publication number Publication date
AU2002360387A1 (en) 2003-06-10
EP1453816A2 (en) 2004-09-08
JP4602668B2 (ja) 2010-12-22
HK1069383A1 (en) 2005-05-20
CA2465641A1 (en) 2003-06-05
US20050119502A1 (en) 2005-06-02
EP1453816B1 (en) 2013-09-18
AU2002360387B2 (en) 2008-08-07
JP2005519875A (ja) 2005-07-07
CN1596248A (zh) 2005-03-16
MXPA04004567A (es) 2004-09-10
WO2003045306A2 (en) 2003-06-05
NZ532597A (en) 2006-04-28
EP1453816A4 (en) 2005-02-09
CA2465641C (en) 2011-06-21
ES2431630T3 (es) 2013-11-27
CN1596248B (zh) 2012-05-09
US7297794B2 (en) 2007-11-20
WO2003045306A3 (en) 2003-09-04
ZA200403572B (en) 2005-09-28

Similar Documents

Publication Publication Date Title
BR0207872A (pt) Composto para liberar agentes ativos, composição, forma de unidade de dosagem e método de administração
MXPA04004567A (es) Compuestos y composiciones de fenoxi amina para adminstrar agentes activos.
BR0112311A (pt) Compostos e composições para liberar agentes ativos, forma de dosagem unitária, método para preparar ditas composições e seu uso
BRPI0015567B8 (pt) composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
BR0306870A (pt) Composição farmacêutica oral, e, método para preparar a mesma
BR9510168A (pt) Composto poliaminoácido composição forma unitária de dosagem e método par epreparar uma composição
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
BR9912975A (pt) Composto e composições para liberação de agentes ativos, método para sua obtenção e seu uso
MXPA02002249A (es) Composiciones farmaceuticas agradables al paladar para animales de compania.
MXPA05013587A (es) Agentes terapeuticos utiles para el tratamiento del dolor.
NO20011721D0 (no) N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
SE9900961D0 (sv) Novel compounds
MXPA05007609A (es) Antagonista de un receptor sensible al calcio.
WO2002015959A3 (en) Compounds and compositions for delivering active agents
MY141012A (en) Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
WO2002100338A3 (en) Compound and composition for delivering active agents
BR0114395A (pt) Composição farmacêutica para administração por suprimento via oral
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments
NZ523606A (en) Pharmaceutical compositions and methods for use
DE69828522D1 (de) Antithrombotische mittel
AU2001244999A1 (en) Naphthamide neurokinin antagonists for use as medicaments
WO2005062874A3 (en) Compounds and compositions for delivering active agents

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA INT.CL: C07C 217/30, C07C 217/22, C07D 233/54, C07D 233/60, C07D 233/64, C07D 295/08, C07D 295/092, A61K 38/00, A61K 38/21, A61K 38/22, A61K 38/28, A61K 38/43, A61K 47/18, A61K 47/16, A61K 47/22, A61K 9/00

Ipc: C07D 265/30 (2011.01), C07D 265/32 (2011.01), C07D

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]